In fact, clinical trial data show GLP-1-treated groups had slightly lower rates of depressive symptoms compared to controls in landmark trials like the STEP studies
The SOUL trial achieved its primary objective by demonstrating a statistically significant and superior reduction in MACE of 14% with oral semaglutide compared to placebo
Coverage for GLP-1 medications (such as semaglutide and tirzepatide) and obesity treatment varies significantly across Cigna plans in Arizona
52(1):3549 Weidhase R, Kramell H-M, Lehmann J, Liebisch H-W, Lerbs W, Parthier B (1987) Methyl jasmonate-induced changes in the polypeptide pattern of senescing barley leaf segments
UnnoKFurushimaDHamamotoSIguchiKYamadaHMoritaAet alStress-reducing effect of cookies containing matcha green tea: essential ratio among theanine, arginine, caffeine and epigallocatechin gallate